Table 1.
Patient information
| Patient Number | Age at SEEG Recording (Years) | Sex | Engel Outcome | SEEG Length (Minutes) | Age at Epilepsy Onset (Years) | Pathology |
|---|---|---|---|---|---|---|
| Good Outcome | ||||||
| 1 | 26 | F | I | 30 | 14 | FCD (non‐specified) |
| 2 | 16 | M | I | 30 | 4 | FCD 2A |
| 3 | 22 | M | I | 30 | 9 | FCD 2B |
| 4 | 28 | F | I | 30 | 8 | FCD 2B |
| 5 | 42 | M | I | 30 | 6 | FCD 2B |
| 6 | 22 | M | IA | 30 | 5 | HS |
| 7 | 39 | M | I | 30 | 17 | FCD 2B |
| 8 | 35 | M | I | 30 | 10 | FCD 2A |
| 9 | 36 | M | I | 30 | 16 | FCD 2A |
| 10 | 37 | M | I | 30 | 5 | FCD 2B |
| 11 | 55 | F | I | 30 | 5 | HS |
| 12 | 43 | F | I | 60 | 28 | FCD 2A |
| 13 | 21 | F | I | 30 | 12 | FCD 2B |
| 14 | 36 | M | I | 60 | 20 | PNH |
| 15 | 26 | F | I | 30 | 12 | FCD (non‐specified) |
| 16 | 32 | F | I | 60 | 17 | FCD 3D |
| 17 | 14 | M | I | 30 | 3 | FCD 2B |
| Poor Outcome | ||||||
| 18 | 26 | F | III | 60 | 1 | Non‐specific |
| 19 | 43 | F | IVA | 30 | 30 | Gliosis |
| 20 | 39 | F | IIB | 30 | 8 | FCD 2A |
| 21 | 35 | M | IVA | 30 | 7 | FCD 2A |
| 22 | 53 | F | IVA | 60 | 14 | Ganglioma |
| 23 | 26 | F | IIIB | 30 | 7 | Gliosis |
| 24 | 29 | F | III | 30 | 15 | FCD 2A, HS |
| 25 | 47 | M | IVB | 30 | 0.5 | FCD2A |
| 26 | 29 | F | IVA | 30 | 21 | FCD 2A |
| 27 | 20 | M | IIIB | 30 | 9 | Gliosis |
| 28 | 22 | F | IVA | 30 | 12 | PNH |
| 29 | 22 | F | IIIA | 30 | 17 | HS |
| 30 | 37 | M | IVB | 30 | 18 | Gliosis |
| 31 | 33 | F | IIIA | 30 | 18 | Gliosis |
| 32 | 38 | M | IIA | 30 | 8 | FCD 1B |
| 33 | 37 | F | II | 30 | 27 | FCD (non‐specified) |
| 34 | 35 | M | IIB | 30 | 19 | FCD 2A |
| 35 | 23 | F | IVB | 30 | 18 | FCD 2B |
| 36 | 27 | F | IVB | 30 | 9 | Gliosis |
| 37 | 33 | M | IVB | 30 | 10 | FCD 2B |
| 38 | 35 | M | IIIA | 30 | 30 | FCD 2A |
| 39 | 30 | M | IVB | 30 | 8 | Gliosis |
Abbreviations: FCD, focal cortical dysplasia; HS, hippocampal sclerosis; PNH, periventricular nodular heterotopia.